TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11679500

Group type: EXPERIMENTAL
Intervention: Gonadotrophin-releasing hormone antagonist (cetrorelix) at 0.25 mg/day with recombinant FSH 150 IU/day for 21 cycles
Number of subjects: 41

Group type: COMPARATOR
Intervention: Recombinant FSH 150 IU/day alone for 27 cycles
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 41
Study: 10204639

Group type: EXPERIMENTAL
Intervention: Large-scale school-based HIV prevention campaign
Number of subjects: 3866
Study: 7977065

Group type: EXPERIMENTAL
Intervention: Metoprolol 200 mg once daily
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Diltiazem 60 mg 4 times daily
Number of subjects: 32
Study: 2566942

Group type: COMPARATOR
Intervention: Placebo before GHRH
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Glucose (100 g p.o. 45 min before GHRH)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Pyridostigmine (120 mg p.o. 60 min before GHRH)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Pyridostigmine plus glucose plus GHRH (administered at ‐60, ‐45 and 0 min)
Number of subjects: 7
Study: 50159

Group type: EXPERIMENTAL
Intervention: Delta-9-tetrahydrocannabinol (THC) 20 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Delta-9-tetrahydrocannabinol (THC) 10 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 31741204

Group type: COMPARATOR
Intervention: In-person MOVE
Number of subjects: 276

Group type: COMPARATOR
Intervention: WebMOVE
Number of subjects: 276
Study: 29934985

Group type: EXPERIMENTAL
Intervention: Medial knee pain (MP) induced by hypertonic saline (0.5 mL) injection
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Lateral knee pain (LP) induced by hypertonic saline injection
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Medial knee pain (MP)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Lateral knee pain (LP)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (Isotonic saline injection)
Number of subjects: 14
Study: 28669654

Group type: EXPERIMENTAL
Intervention: 3% H2 gas inhalation (1 hour twice a day for 2 weeks)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional intravenous medications (for the initial 7 days)
Number of subjects: 50
Study: 26670436

Group type: EXPERIMENTAL
Intervention: Right ventricular outflow tract septal pacing (RVOTs)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Right ventricular apex pacing (RVA)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Both RVOTs and RVA groups
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: RVOTs pacing
Number of subjects: 192
Study: 23197250

Group type: COMPARATOR
Intervention: Fluvastatin 20 mg
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Fluvastatin 20 mg plus Ezetimibe 10 mg
Number of subjects: 54
Study: 21645439

Group type: EXPERIMENTAL
Intervention: UDCA combined with glucocorticoids
Number of subjects: 19

Group type: COMPARATOR
Intervention: UDCA-monotherapy
Number of subjects: 19
Study: 18075220

Group type: COMPARATOR
Intervention: 400 mg/day of plant sterol in 15 g dressing for 4 weeks
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: 800 mg/day of plant sterol in 15 g dressing for 4 weeks
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: 1200 mg/day of plant sterol in 15 g dressing for 4 weeks
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: 2400 mg/day of plant sterol in 45 g dressing for 4 weeks
Number of subjects: 89
Study: 16545905

Group type: EXPERIMENTAL
Intervention: 677T allele in patients with bipolar disorder (BDI)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: 677T allele in patients with schizophrenia
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: 677T allele in male patients with bipolar disorder (BDI)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: 677T allele in male patients with schizophrenia
Number of subjects: 400
Study: 12872337

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 10734658

Group type: EXPERIMENTAL
Intervention: All-trans-retinoic acid (ATRA) administered during the first days of the induction phase (median: 9 days, range: 2‐27 days)
Number of subjects: 27

Group type: COMPARATOR
Intervention: No ATRA administration
Number of subjects: 27
Study: 9182474

Group type: EXPERIMENTAL
Intervention: Mefloquine (250 mg per week, preceded by a loading dose of 250 mg/d for 3 days)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Doxycycline (100 mg per day)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Placebo for both drugs
Number of subjects: 204
Study: 7584000

Group type: EXPERIMENTAL
Intervention: Elective lymph node dissection (ELND)
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: Delayed lymph node dissection (DLND)
Number of subjects: 612

Group type: COMPARATOR
Intervention: Control group (no lymph node dissection)
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: Wide excision of primary lesions
Number of subjects: 612
Study: 2957520

Group type: EXPERIMENTAL
Intervention: Functional restoration treatment program
Number of subjects: 116

Group type: COMPARATOR
Intervention: Nontreatment comparison group
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Small treatment dropout group
Number of subjects: 116
Study: 31896537

Group type: EXPERIMENTAL
Intervention: Corrective exercise program
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study: 30104309

Group type: EXPERIMENTAL
Intervention: Hybrid closed-loop (HCL) insulin delivery using MiniMed Medtronic 670G system
Number of subjects: 0
Study: 27018874

Group type: EXPERIMENTAL
Intervention: Prophylactic clipping
Number of subjects: 1499

Group type: COMPARATOR
Intervention: Non-clipping
Number of subjects: 1499
Study: 26580872

Group type: EXPERIMENTAL
Intervention: Topical Fluorouracil 5% cream (5‐FU) pretreated for 6‐7 days with ALA/PDT
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Topical Fluorouracil 5% cream (5‐FU) BID for 6‐7 days without ALA/PDT
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: No pretreatment, ALA applied with incubation of 2 hours, illuminated treated areas with 10 J/cm2 with Blu‐U device
Number of subjects: 30

Group type: COMPARATOR
Intervention: 5‐FU re‐challenge for 6 days after initial treatment
Number of subjects: 30
Study: 22961573

Group type: EXPERIMENTAL
Intervention: RM-131 (100 μg s.c.)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 21237552

Group type: EXPERIMENTAL
Intervention: SimBaby high-fidelity patient simulator
Number of subjects: 20
Study: 19544672

Group type: EXPERIMENTAL
Intervention: Oral calcium carbonate (CAL, 1.2 to 1.8 g/day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (CTL)
Number of subjects: 20
Study: 16965203

Group type: EXPERIMENTAL
Intervention: Olanzapine (5-20 mg/day)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 12888143

Group type: EXPERIMENTAL
Intervention: Repeat percutaneous coronary intervention
Number of subjects: 225

Group type: COMPARATOR
Intervention: Coronary artery bypass grafting
Number of subjects: 225
Study: 11111139

Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation
Number of subjects: 24

Group type: COMPARATOR
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 24
Study: 9361938

Group type: EXPERIMENTAL
Intervention: Cyclosporine microemulsion (NEO)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Sandimmune (SIM)
Number of subjects: 101
Study: 8236070

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (500 micrograms twice a day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 3912618

Group type: EXPERIMENTAL
Intervention: T-CAF (Chemotherapy plus Tamoxifen)
Number of subjects: 474

Group type: COMPARATOR
Intervention: CAF (Chemotherapy only)
Number of subjects: 474

Group type: COMPARATOR
Intervention: T-CAF and CAF
Number of subjects: 474
Study: 31070490

Group type: EXPERIMENTAL
Intervention: Infrapatellar nerve block with 5 ml 2% lidocaine
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo (sodium chloride 0.9%)
Number of subjects: 34
Study: 29084041

Group type: EXPERIMENTAL
Intervention: booklet/DVD DA
Number of subjects: 34

Group type: COMPARATOR
Intervention: online DA
Number of subjects: 34
Study: 26253006

Group type: EXPERIMENTAL
Intervention: High dose CD34+ stem cells (10 to 15 × 10^6 cells/kg)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard dose CD34+ stem cells (4 to 6 × 10^6 cells/kg)
Number of subjects: 80
Study: 24458745

Group type: EXPERIMENTAL
Intervention: Plyometric exercise (PlyEx) training (8 weeks)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: PlyEx (1stPlyEx)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control group (no jumping activity)
Number of subjects: 11
Study: 23033241

Group type: EXPERIMENTAL
Intervention: linagliptin 5 mg once daily
Number of subjects: 133

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 133
Study: 20671063

Group type: EXPERIMENTAL
Intervention: Patients with Alzheimer's disease (AD)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Patients with idiopathic normal pressure hydrocephalus (iNPH)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 43
Study: 18154425

Group type: EXPERIMENTAL
Intervention: High glycemic index diet
Number of subjects: 16

Group type: COMPARATOR
Intervention: Low glycemic index diet
Number of subjects: 16
Study: 15726101

Group type: EXPERIMENTAL
Intervention: Chemoprophylaxis for Pneumocystis jirovecii pneumonia (PCP)
Number of subjects: 73

Group type: COMPARATOR
Intervention: High-dose corticosteroid therapy (> or =25 mg prednisolone or > or =4 mg dexamethasone daily for > or =4 weeks)
Number of subjects: 73
Study: 12576886

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 26

Group type: COMPARATOR
Intervention: Conventional surgery
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Both surgical approaches
Number of subjects: 26
Study: 10588995

Group type: EXPERIMENTAL
Intervention: Zafirlukast 20 mg twice daily
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Zafirlukast 80 mg twice daily
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 7594041

Group type: EXPERIMENTAL
Intervention: Intracoronary saline infusion during excimer laser coronary angioplasty
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional laser irradiation in a blood medium
Number of subjects: 0
Study: 1963650

Group type: EXPERIMENTAL
Intervention: Conjugated estrogens (0.6 mg/kg/day for 5 days)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 656284

Group type: EXPERIMENTAL
Intervention: Intra-articular prednisolone acetate (50 mg and 100 mg)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Intra-articular prednisolone analogues (three types)
Number of subjects: 46
Study: 29654506

Group type: EXPERIMENTAL
Intervention: Training of Chinese American Community Health Workers (CHWs)
Number of subjects: 43
Study: 28705153

Group type: EXPERIMENTAL
Intervention: TDF/FTC tablet once daily (Perfect adherence)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: TDF/FTC tablet 4 times/week (Moderate adherence)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: TDF/FTC tablet 2 times/week (Low adherence)
Number of subjects: 30
Study: 25455544

Group type: EXPERIMENTAL
Intervention: Transcatheter Aortic Valve Replacement (TAVR)
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: Balloon Aortic Valvuloplasty (BAV)
Number of subjects: 358

Group type: COMPARATOR
Intervention: Medical Management (MM)
Number of subjects: 358
Study: 24683783

Group type: EXPERIMENTAL
Intervention: Buccal midazolam spray
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intranasal midazolam spray
Number of subjects: 30
Study: 21076361

Group type: EXPERIMENTAL
Intervention: Low-dose methadone (0.1 mg/kg/dose)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: High-dose methadone (based on weight and fentanyl infusion rate)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Low-dose methadone
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: High-dose methadone
Number of subjects: 78
Study: 19801052

Group type: EXPERIMENTAL
Intervention: Twice-daily physiotherapy
Number of subjects: 57

Group type: COMPARATOR
Intervention: Once-daily physiotherapy (Control)
Number of subjects: 57
Study: 16454796

Group type: EXPERIMENTAL
Intervention: Hedström files
Number of subjects: 60

Group type: COMPARATOR
Intervention: RaCe rotary instruments
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Epiphany
Number of subjects: 60

Group type: COMPARATOR
Intervention: Gutta‐percha
Number of subjects: 60
Study: 14755001

Group type: EXPERIMENTAL
Intervention: Pre-dive exercise (treadmill running at 90% of maximum heart rate for 3 min, followed by 50% for 2 min, repeated eight times for a total of 40 min)
Number of subjects: 12

Group type: COMPARATOR
Intervention: No pre-dive exercise (control)
Number of subjects: 12
Study: 11264335

Group type: EXPERIMENTAL
Intervention: Moclobemide plus interpersonal therapy (IPT)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Moclobemide and routine clinical management
Number of subjects: 35
Study: 9272198

Group type: EXPERIMENTAL
Intervention: Pirlindole (150-300 mg daily)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Moclobemide (300-600 mg daily)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Pirlindole
Number of subjects: 116

Group type: COMPARATOR
Intervention: Moclobemide
Number of subjects: 116
Study: 8100105

Group type: EXPERIMENTAL
Intervention: Dihydroergotamine (DHE) 0.5 mg subcutaneously
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Dihydroergotamine (DHE)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Intraoperative characteristics
Number of subjects: 40
Study: 3555057

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 500 mg twice daily for five days
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 29313753

Group type: EXPERIMENTAL
Intervention: 2 eggs per day
Number of subjects: 50

Group type: COMPARATOR
Intervention: Oatmeal (one packet per day)
Number of subjects: 50
Study: 27110573

Group type: EXPERIMENTAL
Intervention: EAAs (8 g/day for 14 days)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 60
Study: 24065043

Group type: EXPERIMENTAL
Intervention: Taurine (3 g/day)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (3 g/day starch flour)
Number of subjects: 16
Study: 22583956

Group type: EXPERIMENTAL
Intervention: Coping information (presented with high threat or low threat smoking-related photo)
Number of subjects: 64

Group type: COMPARATOR
Intervention: High risk information (presented with high threat or low threat smoking-related photo)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Coping information (presented with low threat photo)
Number of subjects: 64

Group type: COMPARATOR
Intervention: High risk information (presented with low threat photo)
Number of subjects: 64

Group type: COMPARATOR
Intervention: High threat photos
Number of subjects: 64
Study: 20025642

Group type: EXPERIMENTAL
Intervention: 3 mg melatonin for 21 days
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 18201810

Group type: EXPERIMENTAL
Intervention: YGS (yi-gan san) 7.5 g/day for 12 weeks
Number of subjects: 22
Study: 15919151

Group type: EXPERIMENTAL
Intervention: Scheduled sleep/darkness
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 12633920

Group type: EXPERIMENTAL
Intervention: Corticosteroid (prednisolone 2 mg/kg per day)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Antihistamine (chlorpheniramine maleate 0.35 mg/kg per day)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 10389090

Group type: EXPERIMENTAL
Intervention: Modafinil 400 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Modafinil (combined group of normal and narcoleptic subjects)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (combined group of normal and narcoleptic subjects)
Number of subjects: 24
Study: 8778359

Group type: EXPERIMENTAL
Intervention: New technique for studying incision depth
Number of subjects: 0
Study: 1712957

Group type: EXPERIMENTAL
Intervention: VVIR pacing mode
Number of subjects: 11

Group type: COMPARATOR
Intervention: VVI pacing mode
Number of subjects: 11
Study: 6406439

Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 0
Study: 30714880

Group type: EXPERIMENTAL
Intervention: CBT4CBT-Buprenorphine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard buprenorphine treatment
Number of subjects: 20
Study: 28213645

Group type: EXPERIMENTAL
Intervention: Anodal tDCS over the left dorsolateral prefrontal cortex (DLPFC, 1 mA, 20 min)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 16
Study: 26355615

Group type: EXPERIMENTAL
Intervention: Clindamycin phosphate 1.2% and benzoyl peroxide 3.75% aqueous gel
Number of subjects: 498

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 498
Study: 23697871

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR) program
Number of subjects: 200

Group type: COMPARATOR
Intervention: Waitlist Control group
Number of subjects: 200
Study: 20732776

Group type: EXPERIMENTAL
Intervention: Pedometer-based behavioral modification program with telephone support
Number of subjects: 92
Study: 19999359

Group type: EXPERIMENTAL
Intervention: 1-hour reading aloud task (exercise)
Number of subjects: 9

Group type: COMPARATOR
Intervention: 24-hour period of complete voice rest (control)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Half-dose injection plus exercise
Number of subjects: 9
Study: 15987748

Group type: EXPERIMENTAL
Intervention: MMF group (n = 54)
Number of subjects: 108

Group type: COMPARATOR
Intervention: CsA group (n = 54)
Number of subjects: 108
Study: 12888370

Group type: EXPERIMENTAL
Intervention: Prevalence screening
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Incidence screening
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-progressive DCIS (DCIS(0))
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Progressive DCIS (DCIS(1))
Number of subjects: 0
Study: 18425650

Group type: EXPERIMENTAL
Intervention: Reward (special dessert)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Insisting children try one bite
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Choice-offering ('Do you want any of this?')
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Modeling
Number of subjects: 64

Group type: COMPARATOR
Intervention: Simple exposure (control condition)
Number of subjects: 64
Study: 8664370

Group type: EXPERIMENTAL
Intervention: Intensive 8-hour training course and supporting materials
Number of subjects: 0
Study: 1829177

Group type: EXPERIMENTAL
Intervention: Intravenous hydantoin injection followed by dose-adjusted oral administration for a minimum of 3 months
Number of subjects: 86

Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 86
Study: 6222257

Group type: EXPERIMENTAL
Intervention: Clodronate
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31713863

Group type: EXPERIMENTAL
Intervention: Extended anticoagulation
Number of subjects: 281

Group type: COMPARATOR
Intervention: Standard treatment (limited duration anticoagulation)
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: D-dimer results (on anticoagulation)
Number of subjects: 281
Study: 30523703

Group type: EXPERIMENTAL
Intervention: TEA plus usual care (TU)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 106
Study: 28216012

Group type: EXPERIMENTAL
Intervention: HMME group (treated with Hemoporfin)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo group (given normal saline)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (received HMME-PDT treatment in the second session)
Number of subjects: 50
Study: 26797500

Group type: EXPERIMENTAL
Intervention: LL group (three standard fluoroscopic views + LL fluoroscopic view)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Standard group (three standard fluoroscopic views)
Number of subjects: 143
Study: 23905837

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (n=20)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Sulfonylurea (n=24)
Number of subjects: 198
Study: 22015710

Group type: EXPERIMENTAL
Intervention: Structured diet and exercise (DE)
Number of subjects: 16

Group type: COMPARATOR
Intervention: DE plus metformin
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: DE (with improvement in V˙O2max)
Number of subjects: 16
Study: 19356395

Group type: EXPERIMENTAL
Intervention: Test formulation of levofloxacin 500 mg
Number of subjects: 27

Group type: COMPARATOR
Intervention: Reference formulation of levofloxacin 500 mg
Number of subjects: 27
Study: 17637533

Group type: EXPERIMENTAL
Intervention: Extended lymphadenectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with gemcitabine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (standard treatment)
Number of subjects: 0
Study: 16639920

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of recombinant tissue-type plasminogen activator (rt-PA): 3 mg dissolved in 250 mg of physiological saline given every 12 hours for a maximum of 20 days.
Number of subjects: 150

Group type: COMPARATOR
Intervention: Standard dosage of rt-PA used for treatment of myocardial infarction (not specified in the abstract).
Number of subjects: 150
Study: 11817910

Group type: EXPERIMENTAL
Intervention: PACE+ intervention (computerized assessment and tailored action plans)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Mail only, infrequent phone and mail, frequent phone and mail (extended intervention conditions)
Number of subjects: 173
Study: 9469313

Group type: EXPERIMENTAL
Intervention: Tibial components inserted with cement
Number of subjects: 26

Group type: COMPARATOR
Intervention: Tibial components inserted without cement
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Both groups (with and without cement)
Number of subjects: 26
Study: 10150841

Group type: EXPERIMENTAL
Intervention: Retrobulbar anesthesia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Peribulbar anesthesia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonsteroidal anti-inflammatory drugs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotic use
Number of subjects: 0